Posts

Trailblazing Psychedelic Researcher Transforms Psychiat...

In recent years, the field of psychedelic medicine has undergone a remarkable re...

The Controversial Importance of Regulating Stem Cell-De...

The evolution of stem cell research has ushered in a new frontier in development...

Revolutionizing Electric Motors: KIST Unveils CNT-Based...

In a groundbreaking leap towards sustainable technology, researchers at the Kore...

Stanford Scientist Uncovers How Sugar Molecules Shield ...

In a groundbreaking development poised to redefine the landscape of neurodegener...

Italian Neuroscientist Uncovers Lasting Brain Impact of...

In a groundbreaking interview published in the forthcoming issue of Brain Medici...

Quality of Life Predicts Colon Cancer Outcomes

Health-Related Quality of Life Emerges as a Critical Prognostic Indicator in Col...

New Study Reveals Migrant Status Intensifies Inequality...

Ethnic minority healthcare professionals who were born outside the United Kingdo...

Androgen-Driven AR-BRD4 Complex Fuels Osteosarcoma Growth

In a groundbreaking study set to reshape our understanding of osteosarcoma proli...

Hypoxia Boosts MS via Macrophage Inflammasome Activation

In an unprecedented leap forward in our understanding of multiple sclerosis (MS)...

Cleveland Clinic Study Reveals Injectable Obesity Medic...

A recent comprehensive study conducted by researchers at the Cleveland Clinic sh...

Polygenic Insights into Mumps Vaccine Immune Response

In a groundbreaking advancement in the field of immunogenetics, researchers have...

Ascletis Reports Phase 3 Success for Oral Acne Drug Den...

Ascletis Pharma has announced topline results from a phase 3 clinical trial eval...

RegenXBio Reports Functional Gains and Safety in Phase ...

RegenXBio has released an update on its Phase 1/2 clinical trial evaluating the ...

The European Market Access Lag: 2021–2024

In this article, GlobalData examines key reimbursement trends that reflect the c...

EC approves AstraZeneca’s acalabrutinib combo for CLL

The EC has granted approval for a fixed-duration regimen of AstraZeneca's Calque...

Mount Sinai Researchers Unveil Groundbreaking Findings ...

Sleep Medicine Breakthroughs from Mount Sinai Experts Revealed at SLEEP 2025 Con...